[15886] in Public-Access_Computer_Systems_Forum
Hot Pick Monthly
daemon@ATHENA.MIT.EDU (Sara Luna)
Mon Jun 27 05:38:42 2005
Message-ID: <000e01c57b60$9465e5f0$92784100@mzepz>
From: "Sara Luna" <dacarters@comcast.net>
To: <nathanh@mit.edu>
Date: Mon, 27 Jun 2005 16:57:16 -0500
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_000B_01C57B3F.0D5445F0"
This is a multi-part message in MIME format.
------=_NextPart_000_000B_01C57B3F.0D5445F0
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: 7Bit
HOT SHOT STOCK ALERT -- INTERNET IPO!!!!!!
EXCITING ISSUE PGCN GET IN NOW!!!
(OTC Ticker: PGCN)
Current Price $2.48
5-Day Target: $6
10-Day Target: $11
3-Month Target: $25-28 or Higher
!!!!!!PRESS RELEASE!!!!PRESS RELEASE!!!!!PRESS RELEASE!!!!!
Pingchuan Signed Market Research Consignment Agreement With Moscow Sing
Sing
Co. Ltd
Thursday June 23, 10:31 am ET
HARBIN, China, June 23 /Xinhua-PRNewswire/ -- Pingchuan Pharmaceutical
Inc.
(OTC Bulletin Board: PGCN - News; "PINGCHUAN") announced today that
PINGCHUAN signed a market research consignment agreement with Moscow Sing
Sing Co. Ltd ("SING SING").
ADVERTISEMENT
According to the agreement, SING SING authorized PINGCHUAN as its
exclusive
partner to conduct market researches for business projects in P. R. China
(exclude Hong Kong, Macao and Taiwan). PINGCHUAN promises to accomplish
commercial market researches and deliver business plans for SING SING
within
the valid period of the agreement. The co-operation with SING SING, will
bring in revenue of USD 200,000 for PINGCHUAN.
**************HERE IS ANOTHER GOOD REASON TO LOOK AT
PGCN************************
Pingchuan Pharmaceutical Inc. ("PINGCHUAN") is a modernized
pharmaceutical manufacturer with first-class medical R&D ability,
pioneered
medicine products, and well-established marketing network. Since its
establishment, PINGCHUAN has focused its businesses on diabetes medicine
and
its medical products. The products of PINGCHUAN include health care
products, varieties of medicine, as well as medical apparatus. Kang Da
Glycosuria Capsule is a successful product of PINGCHUAN for treating
diabetes, which was first developed in 1998 and introduced to the market
in
2001. PINGCHUAN has well-established marketing network and sale branches,
which include about 180,000 retail pharmacies/drugstores across China,
agency network in major cities like Beijing, Shanghai, Guangzhou, and
Xi'an,
special counter sale at drug chain stores in key regions, residence
community clinic sale and promotion, as well as internet marketing through
the company's website. The marketing network of PINGCHUAN covers more than
50% districts of China and exports to US, Japan, Russia, and south-eastern
Asia.
Sick of hedge funds and flippers getting all the great new issues? Most
stock brokers give out their new issues to their largest commission paying
clients---and if you trade through an online broker or discount
broker---good luck ever getting 1 share of a new issue.
WELL ALL THAT IS CHANGING -- THIS IS AN ONLINE INTERNET IPO. IF YOU ARE
RECEIVING THIS EMAIL, YOU ARE AMONG THE FIRST PUBLIC INVESTORS TO KNOW
ABOUT
PGCN !!!!
Remember the gains from our recent Strong Buy recommendations...
It is only a matter of time before it is released out into the investment
community and they take it to the moon..
PGCN---PGCN----PGCN----PGCN----PGCN----PGCN----PGCN----PGCN----PGCN----PGCN-
---PGCN----PGCN
after visiting a Thai village ravaged by
the disaster which killed more than 200000
in a dozen countries The two former
leaders have been asked by the White
------=_NextPart_000_000B_01C57B3F.0D5445F0
------=_NextPart_000_000B_01C57B3F.0D5445F0--
